Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

981 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report.
Desai A, Rakshit S, Bansal R, Ashara Y, Potter A, Manochakian R, Lou Y, Zhao Y, Ernani V, Savvides P, Schwecke A, Moffett N, Hocum C, Leventakos K, Adjei A, Marks R, Molina J, Mansfield AS, Chen ZM, Dimou A. Desai A, et al. Among authors: potter a. Cancer Treat Res Commun. 2023;36:100743. doi: 10.1016/j.ctarc.2023.100743. Epub 2023 Jul 13. Cancer Treat Res Commun. 2023. PMID: 37531736 Free article.
Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab.
Gao RW, Day CN, Yu NY, Bush A, Amundson AC, Prodduturvar P, Majeed U, Butts E, Oliver T, Schwecke AJ, Moffett JN, Routman DM, Breen WG, Potter AL, Rivera-Concepcion J, Hoppe BS, Schild SE, Sio TT, Lou Y, Ernani V, Ko S, Olivier KR, Merrell KW, Garces YI, Manochakian R, Harmsen WS, Leventakos K, Owen D. Gao RW, et al. Among authors: potter al. Lung Cancer. 2022 Aug;170:58-64. doi: 10.1016/j.lungcan.2022.06.003. Epub 2022 Jun 13. Lung Cancer. 2022. PMID: 35716632
Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer.
Desai A, Smith CJ, Ashara Y, Orme JJ, Zanwar S, Potter A, Hocum C, Moffett JN, Schwecke AJ, Manochakian R, Lou Y, Zhao Y, Ernani V, Savvides P, Molina J, Dimou A, Mansfield AS, Parikh K, Leventakos K. Desai A, et al. Among authors: potter a. Clin Lung Cancer. 2023 Dec;24(8):689-695.e1. doi: 10.1016/j.cllc.2023.09.001. Epub 2023 Sep 17. Clin Lung Cancer. 2023. PMID: 37880074 Free article.
Capmatinib-Associated Pseudoacute Kidney Injury in Nonsmall Cell Lung Cancer.
Sandoval L, Radhakrishnan Y, Vaughan LE, Potter A, Mansfield AS, Herrmann SM. Sandoval L, et al. Among authors: potter a. Kidney Int Rep. 2023 Aug 28;8(11):2482-2485. doi: 10.1016/j.ekir.2023.08.032. eCollection 2023 Nov. Kidney Int Rep. 2023. PMID: 38025245 Free PMC article. No abstract available.
Characterizing the blood stage antimalarial activity of pyronaridine in healthy volunteers experimentally infected with Plasmodium falciparum.
Barber BE, Webster R, Potter AJ, Llewellyn S, Sahai N, Leelasena I, Mathison S, Kuritz K, Flynn J, Chalon S, Marrast AC, Gobeau N, Moehrle JJ. Barber BE, et al. Among authors: potter aj. Int J Antimicrob Agents. 2024 May 9:107196. doi: 10.1016/j.ijantimicag.2024.107196. Online ahead of print. Int J Antimicrob Agents. 2024. PMID: 38734217
Early Detection and Interception of Lung Cancer.
Chang AEB, Potter AL, Yang CJ, Sequist LV. Chang AEB, et al. Among authors: potter al. Hematol Oncol Clin North Am. 2024 May 8:S0889-8588(24)00031-5. doi: 10.1016/j.hoc.2024.03.004. Online ahead of print. Hematol Oncol Clin North Am. 2024. PMID: 38724286 Review.
981 results